Drug Safety

A Model for Decision Support in Signal Triage
pp. 727-735(9)
Authors: Levitan, Bennett; Yee, Chuen L.; Russo, Leo; Bayney, Richard; Thomas, Adrian P.; Klincewicz, Stephen L.

On Pharmaceutical Risk Minimization
pp. 737-742(6)
Authors: Callréus, Torbjörn

RevAssist®: A Comprehensive Risk Minimization Programme for Preventing Fetal Exposure to Lenalidomide
pp. 743-752(10)
Authors: Castaneda, Carmen P.; Zeldis, Jerome B.; Freeman, John; Quigley, Curtis; Brandenburg, Nancy A.; Bwire, Robert

Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections
pp. 753-768(16)
Authors: Falagas, Matthew E.; Vardakas, Konstantinos Z.

Inhaled Corticosteroids and Adrenal Insufficiency: Prevalence and Clinical Presentation
pp. 769-774(6)
Authors: Molimard, Mathieu; Girodet, Pierre-Olivier; Pollet, Clothilde; Fourrier-Réglat, Annie; Daveluy, Amélie; Haramburu, Françoise; Fayon, Michaël; Tabarin, Antoine

Risk of Hypospadias in Offspring of Women Using Loratadine during Pregnancy: A Systematic Review and Meta-Analysis
pp. 775-788(14)
Authors: Schwarz, Eleanor B.; Moretti, Myla E.; Nayak, Smita; Koren, Gideon

Risk Factors Associated with Adverse Drug Reactions Following Hospital Admission: A Prospective Analysis of 907 Patients in Two German University Hospitals
pp. 789-798(10)
Authors: Zopf, Yurdaguel; Rabe, Christina; Neubert, Antje; Hahn, Eckhart G.; Dormann, Harald

Advice on Drug Safety in Pregnancy: Are there Differences between Commonly Used Sources of Information?
pp. 799-806(8)
Authors: Widnes, Sofia K. Frost; Schjøtt, Jan